Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Summary of findings

From: Strategies for improving treatment retention for buprenorphine/naloxone for opioid use disorder: a qualitative study of issues and recommendations from prescribers

Theme

Issues

Consensus recommendations

Systems and tools to support patient management.

Lack of tools and staff support for tracking patients.

Inadequate tools for assessing patient fit with medication treatment options.

States adopt alert system as part of prescriber monitoring system for missed prescription refills.

Increase investment in developing decision-support tools for assessing the best treatment options for a patient.

Integration of behavioral health with prescribing.

Whether counseling should be required.

Inadequate communication between prescriber and counselor.

Timely access to psychiatrists.

Professional associations establish a policy that counseling should be encouraged but not required.

Treatment programs proactively secure patients’ permission for information exchange between prescriber and counselor.

States establish a web-based clearinghouse for psychiatry services.

Implications of patient volume for effective patient management.

Whether volume thresholds are useful.

State agencies offer guidance to prescribers on appropriate patient volume based on resource availability.

Role of telehealth.

Whether telehealth can fully replace in-person visits for prescriptions.

Professional associations recommend continuation of periodic in-person visits as part of the prescribing schedule.